CD3E and neoplasm: TFAB002s bind to both CD20-expressing tumor cells and CD3ε-expressing T cells, causing crosslinking between T cells and tumor cells, which leads to T-cell activation, tumor cell lysis, and subsequent secretion of cytokines.